Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional) [Phase 4]

View source ↗

Summary

Phase 4 interventional trial exploring how circadian factors regulate neuroplasticity after ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | Conditions: Ischemic Stroke, Acute, Sleep Disorders, Circadian Rhythm | Phase 4 | Status: RECRUITING